Mar 28 |
T2 Biosystems extends contract with Vizient
|
Mar 28 |
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
|
Mar 20 |
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
|
Mar 19 |
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
|
Mar 18 |
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
|
Mar 12 |
T2 Biosystems receives extension to comply with Nasdaq listing requirement
|
Mar 12 |
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
|
Feb 16 |
T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript
|
Feb 16 |
Q4 2023 T2 Biosystems Inc Earnings Call
|
Feb 16 |
T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript
|